Publication:
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Placeholder

Organizational Units

Program

Authors

Esen, Ramazan
Cekdemir, Demet
Guvenc, Serkan
Ozdemirkiran, Fusun
Eser, Ali
Topts, Tayfur
ÖZKOCAMAN, VİLDAN
ŞAHİN, HANDAN HAYDAROĞLU
ERMİŞ TURAK, Esra
Comert, Melda

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).

Description

Source:

Keywords:

Keywords

Citation

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., ŞAHİN H. H. , ERMİŞ TURAK E., Esen R., Comert M., et al., -A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience-, TURKISH JOURNAL OF HEMATOLOGY, cilt.36, ss.230-237, 2019

Endorsement

Review

Supplemented By

Referenced By

1

Views

0

Downloads

View PlumX Details


Sustainable Development Goals